Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?

Since mesenchymal stromal/stem cells (MSCs) were discovered, researchers have been drawn to study their peculiar biological features, including their immune privileged status and their capacity to selectively migrate into inflammatory areas, including tumors. These properties make MSCs promising cel...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Giulia Golinelli, Ilenia Mastrolia, Beatrice Aramini, Valentina Masciale, Massimo Pinelli, Lucrezia Pacchioni, Giulia Casari, Massimiliano Dall’Ora, Milena Botelho Pereira Soares, Patrícia Kauanna Fonseca Damasceno, Daniela Nascimento Silva, Massimo Dominici, Giulia Grisendi
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020-09-01
Collection:Frontiers in Pharmacology
Sujets:
mesenchymal stromal/stem cell
cancer
tumor necrosis factor-related apoptosis-inducing ligand
gene therapy
cell therapy
Accès en ligne:https://www.frontiersin.org/article/10.3389/fphar.2020.529921/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires